This “conformational fingerprinting” capability enables Tau-RT-QuIC to facilitate precise differential diagnosis between AD and other tauopathies like PSP/CBD, thereby guiding clinicians toward more accurate diagnoses and informed treatment decisions (Lathuiliere and Hyman, 2021). This evidence concerns the gene MAPT and tauopathy.